What could you do if your data was working for you and not against you? With Bloomberg delivering

enterprise data directly to your systems, you get easy access to the details you want, optimized for

higher level analysis, and financial data experts committed to helping you maximize your every move.

Our data is made for more, so you can show the world what you're made of. Visit Bloomberg.com slash enterprise data to learn more.

Welcome to Prognosis. I'm Laura Carlson. It's day 198 since coronavirus was declared a global pandemic. Today's main story,

in the U.S., we still don't have as many COVID tests as we need. And when people can get their

hands on tests, they're not always reliable.

But first, here's what happened in virus news today.

The UK added London to its watch list of potential pandemic hotspots as coronavirus cases surge across the country.

The move is fueling fears that the Capitol, which recorded 620 new COVID-19 cases on Thursday,

could face the kind of local lockdown measures imposed on other cities.

Though no new restrictions will be put on London immediately,

its designation as an area of concern means extra testing will be made available,

according to London councils.

In China, annual vaccine capacity is expected to reach 610 million doses

by year end and one billion doses by the end of 2021. That's according to Zhang Zhang Wei,

an official at the National Health Commission. At a briefing in

Beijing, Zheng said prices will be affordable for the public, but did not give specifics. No serious

cases of adverse reaction were reported yet in an emergency use program of China's inoculations.

And finally, in the next few days, the world will officially record 1 million deaths from COVID-19.

But the real tally might be almost double that.

Actual fatalities from the worst pandemic in a century may be closer to 1.8 million.

...